Close Menu

Ganapati Mudur, Julia Karow

Premium

Ganapati Mudur, “Pufferfish, Pigs and Silkworms: Asia Emerges as a Genomics Actor,” p. 40, is a science journalist in New Delhi, India. He has been writing about research as well as policy issues in science, technology, and medicine for 15 years, covering wide-ranging beats — from geosciences to public health to space technology. He was a Knight Science Journalism Fellow at MIT during 1999-2000, a time that he says he spent “gearing up for the century of the genome.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.